http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1088290-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 |
filingDate | 1965-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1967-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | GB-1088290-A |
titleOfInvention | Novel suppositories and a process for the manufacture thereof |
abstract | Suppositories contain 0.3 to 1.6% by weight of dioctyl sodium sulphosuccinate in a base which melts at about body temperature. The term "base" is defined as including ingredients which, although inert in combatting constipation, may have other therapeutic properties. The major base component may be a synthetic or natural wax, e.g. cocoa butter, with or without white beeswax; mono-, di, and tri-glycerides of saturated fatty acids such as Wecobee R, Witepsol, Imhausen and Masses Esterinum suppository bases; and polyethylene glycols. Other active ingredients may be: zinc oxide, phenyl mercuric nitrate, bismuth salts, boric acid, hexachlorophene, allantoin, ephedrine, phenylephrine, d-panthenol and local anaesthetics such as Larocaine (Trade Mark), benzocaine, amprotropin phosphate, and diperodon. The suppositories are useful for softening hard f cal masses. |
priorityDate | 1964-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.